Lower 90-day Hospital Readmission Rates for Esophageal Variceal Bleeding After TIPS: A Nationwide Linked Analysis
- PMID: 30829905
- DOI: 10.1097/MCG.0000000000001199
Lower 90-day Hospital Readmission Rates for Esophageal Variceal Bleeding After TIPS: A Nationwide Linked Analysis
Abstract
Objective: Hospital readmission rates following a transjugular intrahepatic portosystemic shunt (TIPS) insertion after an episode of esophageal variceal bleeding (EVB) has not been well studied. We aimed to address this gap in knowledge on a population level.
Methods: The Nationwide Readmission Database (NRD) was used to study the readmission rates for patients with decompensated cirrhosis who had a TIPS insertion performed for EVB. The NRD is a national database that tracks patients longitudinally for hospital readmissions. A propensity score matching model was created to match patients who received TIPS with those who did not.
Results: A total of 42,679,001 hospital admissions from the 2012 to 2014 NRD sample were analyzed. There were 33,934 patients with EVB who met inclusion criteria for the study, of whom, 1527 (4.5%) received TIPS after EVB and were matched with 1527 patients with EVB who did not undergo TIPS. With a uniform follow-up of 3 months, patients with TIPS were less likely to be readmitted to hospital with a recurrent EVB [odds ratio (OR): 0.33, 95% confidence interval (CI): 0.24-0.47, P<0.01], although were more likely to be readmitted with hepatic encephalopathy (OR: 1.66; 95% CI: 1.31-2.11, P<0.01). At 3 months, there was no difference in all cause hospital readmission rate between the 2 groups (OR: 38.8%; 95% CI: 38.1-44.9 TIPS vs. OR: 41.5%; 95% CI: 34.1-43.3 non-TIPS: P=0.17).
Conclusions: In this large nationally representative study, TIPS insertion after an episode of EVB was associated with a significantly lower risk of 3-month readmission for recurrent EVB compared with patients who did not receive TIPS. Although those receiving TIPS had a higher rate of hepatic encephalopathy the overall readmission remained unchanged.
Similar articles
-
Clinical Outcomes of Transjugular Intrahepatic Portosystemic Shunt Among Cirrhosis Patients With Recurrent Esophageal Variceal Bleeding.Cureus. 2024 Nov 5;16(11):e73101. doi: 10.7759/cureus.73101. eCollection 2024 Nov. Cureus. 2024. PMID: 39651005 Free PMC article.
-
Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.J Gastroenterol Hepatol. 2017 Apr;32(4):852-858. doi: 10.1111/jgh.13593. J Gastroenterol Hepatol. 2017. PMID: 27624167 Free PMC article.
-
Transjugular Intrahepatic Portosystemic Shunts Reduce Variceal Bleeding and Improve Survival in Patients with Cirrhosis: A Population-Based Analysis.J Vasc Interv Radiol. 2020 Sep;31(9):1382-1391.e2. doi: 10.1016/j.jvir.2020.06.005. Epub 2020 Aug 11. J Vasc Interv Radiol. 2020. PMID: 32792277
-
The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S344-51. doi: 10.1097/MCG.0b013e318157e500. J Clin Gastroenterol. 2007. PMID: 17975487 Review.
-
[Research advances in diagnosis and treatment of post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy].Zhonghua Gan Zang Bing Za Zhi. 2016 Jul 20;24(7):545-548. doi: 10.3760/cma.j.issn.1007-3418.2016.07.015. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 27784438 Review. Chinese.
Cited by
-
Readmission Rates in Patients With Multiple Sclerosis: A Nationwide Cohort Study.Int J MS Care. 2022 Sep-Oct;24(5):218-223. doi: 10.7224/1537-2073.2021-089. Epub 2022 May 3. Int J MS Care. 2022. PMID: 36090236 Free PMC article.
-
Clinical Outcomes of Transjugular Intrahepatic Portosystemic Shunt Among Cirrhosis Patients With Recurrent Esophageal Variceal Bleeding.Cureus. 2024 Nov 5;16(11):e73101. doi: 10.7759/cureus.73101. eCollection 2024 Nov. Cureus. 2024. PMID: 39651005 Free PMC article.
-
Hepatic encephalopathy.Nat Rev Dis Primers. 2022 Jun 23;8(1):43. doi: 10.1038/s41572-022-00366-6. Nat Rev Dis Primers. 2022. PMID: 35739133 Review.
-
Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days.Front Med (Lausanne). 2021 May 31;8:646875. doi: 10.3389/fmed.2021.646875. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34136498 Free PMC article.
-
Readmission after TIPS: an up-to-date landscape.Gastroenterol Rep (Oxf). 2019 Nov 28;8(2):83-84. doi: 10.1093/gastro/goz063. eCollection 2020 Apr. Gastroenterol Rep (Oxf). 2019. PMID: 32280466 Free PMC article. No abstract available.
References
-
- D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–231.
-
- Garcia-Tsao G, Friedman S, Iredale J, et al. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology. 2010;51:1445–1449.
-
- Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology. 2009;136:1134–1144.
-
- Nguyen GC, Segev DL, Thuluvath PJ. Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension. Clin Gastroenterol Hepatol. 2007;5:1092–1099.
-
- Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922–938.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous